RecruitingPhase 1NCT05039411

Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease

Studying Anal fistula

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CryoCord Sdn Bhd
Principal Investigator
April Camilla Roslani, Prof. Dr.
Department of Surgery, Faculty of Medicine, University of Malaya
Intervention
PF2020-CELL (UC-MSCs) - Allogeneic Human Umbilical Cord Mesenchymal Stem Cells(biological)
Enrollment
5 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2026

Study locations (1)

Collaborators

University of Malaya

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05039411 on ClinicalTrials.gov

Other trials for Anal fistula

Additional recruiting or active studies for the same condition.

See all trials for Anal fistula →

← Back to all trials